Objective To evaluate whether the single nucleotide polymorphism rs7895833 (A/G) of the gene SIRT1 is associated with metabolic syndrome criteria in a sample of Brazilian adults. Methods Serum samples and oral mucosal cells were collected from 243 subjects aged 30 to 70 years. Biochemical, hormonal, and anthropometric data were obtained. The single nucleotide polymorphism rs7895833 (A/G) was analyzed by polymerase chain reaction using the amplification refractory mutation system. Results Among the 243 study subjects, 100 (41.15%) were classified as non-metabolic syndrome and 143 (58.85%), as metabolic syndrome. The frequency of the single nucleotide polymorphism rs7895833 (A/G) did not differ between the groups. However, 111 patients (45.67%) were overweight (body mass index: 25-29.9 kg/m2). Blood glucose, total cholesterol, triglycerides, very low density lipoprotein, low density lipoprotein, waist and hip circumferences, and blood pressure were higher in the metabolic syndrome group than in the non-metabolic syndrome group. Free thyroxine 4, grown hormone, and insulin levels were within the normal range. The metabolic conditions of the patients with metabolic syndrome indicate biochemical, anthropometric, and hormonal changes characteristic of overweight and obesity. Conclusion The SIRT1 polymorphism rs7895833 (A/G) is not associated with the metabolic syndrome in the adult Brazilian population.291110Ipadeola, A., Adeleye, J.O., The metabolic syndrome and accurate cardiovascular risk prediction in persons with type 2 diabetes Mellitus (2015) Diabetes Metab Syndr, , http://dx.doi.org/10.1016/j.dsx.2015.08.011Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evolution and treatment of high blood cholesterol (2005) JAMA, 285 (19), pp. 2486-2497Barzilai, N., Bartke, A., Biological approaches to mechanistically understand the healthy life Span extension achieved by calorie restriction and modulation of hormones (2009) J Gerontol Biol Sci, 2 (12), pp. 187-191. , http://dx.doi.org/10.1093/gerona/gln061Masoro, E.J., Overview of the effects of food restriction (1989) Prog Clin Biol Res, 287, pp. 27-35Berner, Y.N., Stern, F., Energy restriction controls aging through neuroendocrine signal transduction (2004) Ageing Res Rev, 3 (2), pp. 189-198. , http://dx.doi.org/10.1016/j.arr.2003.10.004Holloszy, J.O., Fontana, L., Caloric restriction in humans (2007) Exp Gerontol, 42 (8), pp. 709-712. , http://dx.doi.org/10.1016/j.exger.2007.03.009Chen, D., Bruno, J., Easlon, E., Lin, S.J., Cheng, H.L., Alt, F.W., Tissue-specific regulation of SIRT1 by calorie restriction (2008) Genes Dev, 22 (13), pp. 1753-1757. , http://dx.doi.org/10.1101/gad.1650608Frye, R.A., Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins (2000) Biochem Biophys Res Commun, 273 (2), pp. 793-798. , http://dx.doi.org/10.1006/bbrc.2000.3000Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Resveratrol improves health and survival of mice on a high-calorie diet (2006) Nature, 444 (7117), pp. 337-342. , http://dx.doi.org/10.1038/nature05354Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha (2006) Cell, 127 (16), pp. 1109-1122. , http://dx.doi.org/10.1016/j.cell.2006.11.013Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma (2004) Nature, 429 (6993), pp. 771-776. , http://dx.doi.org/10.1038/nature02583Boezen, H.M., SIRT1 polymorphism, long-term survival and glucose tolerance in the general population (2013) PLoS One, 8 (3). , http://dx.doi.org/10.1371/journal.pone.0058636Dong, Y., Guo, T., Traurig, M., Mason, C.C., Kobes, S., Perez, J., SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima Indians (2011) Mol Genet Metab, 104 (4), pp. 661-665. , http://dx.doi.org/10.1016/j.ymgme.2011.08.001Zillikens, M.C., van Meurs, J.B., Sijbrands, E.J., Rivadeneira, F., Dehghan, A., van Leeuwen, J.P., SIRT1 genetic variation and mortality in type 2 diabetes: Interaction with smoking and dietary niacin (2009) Free Radic Biol Med, 46 (6), pp. 836-841. , http://dx.doi.org/10.1016/j.freeradbiomed.2008.12.022Peeters, A.V., Beckers, S., Verrijken, A., Mertens, I., Roevens, P., Peeters, P.J., Association of SIRT1 gene variation with visceral obesity (2008) Hum Genet, 124 (4), pp. 431-436. , http://dx.doi.org/10.1007/s00439-008-0567-8Weyrich, P., Machicao, F., Reinhardt, J., Machann, J., Schick, F., Tschritter, O., SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention: The TULIP study (2008) BMC Med Genet, 9, p. 100. , http://dx.doi.org/10.1186/1471-2350-9-100Pedersen, S.B., Olholm, J., Paulsen, S.K., Bennetzen, M.F., Richelsen, B., Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women (2008) Int J Obes, 32 (18), pp. 1250-1255. , http://dx.doi.org/10.1038/ijo.2008.78Shimoyama, Y., Suzuki, K., Hamajima, N., Niwa, T., Sirtuin 1 gene polymorphisms are associated with body fat and blood pressure in Japanese (2011) Transl Res, 157 (6), pp. 339-347. , http://dx.doi.org/10.1016/j.trsl.2011.02.004Zillikens, M.C., Van Meurs, J.B., Rivadeneira, F., Amin, N., Hofman, A., Oostra, B.A., SIRT1 genetic variation is related to BMI and risk of obesity (2009) Diabetes, 58 (12), pp. 2828-2834. , http://dx.doi.org/10.2337/db09-0536Zillikens, M.C., Van Meurs, J.B., Rivadeneira, F., Hofman, A., Oostra, B.A., Sijbrands, E.J., Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index (2010) Am J Clin Nutr, 91 (5), pp. 1387-1393. , http://dx.doi.org/10.3945/ajcn.2009.28627(2004) Obesidade: prevenindo e controlando a epidemia global, , Relatório da Consultoria da OMS. São Paulo: RoccaFriedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge (1972) Clin Chem, 18 (6), pp. 499-502Arruda, V.R., Lima, C.S., Grignoli, C.R., de Melo, M.B., Lorand-Metze, I., Alberto, F.L., Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu1 (GSTM1) and theta1 (GSTT1) gene defects (2001) Eur J Haematol, 66 (6), pp. 383-388. , http://dx.doi.org/10.1034/j.1600-0609.2001.066006383.xShimoyama, Y., Mitsuda, Y., Tsuruta, Y., Suzuki, K., Hamajima, N., Niwa, T., SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients (2012) J Ren Nutr, 22 (1), pp. 114-119. , http://dx.doi.org/10.1053/j.jrn.2011.10.025Zarrabeitia, M.T., Valero, C., Martín-Escudero, J.C., Olmos, J.M., Bolado-Carrancio, A., de Sande-Nacarino, E.L., Association study of sirtuin 1 polymorphisms with bone mineral density and body mass index (2012) Arch Med Res, 43 (5), pp. 363-368. , http://dx.doi.org/10.1016/j.arcmed.2012.06.012Clark, S.J., Falchi, M., Olsson, B., Jacobson, P., Cauchi, S., Balkau, B., Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity (2012) Obesity, 20 (1), pp. 178-185. , http://dx.doi.org/10.1038/oby.2011.200Figarska, S.M., Vonk, J.M., Boezen, H.M., SIRT1 polymorphism, long-term survival and glucose tolerance in the general population (2013) PLoS One, 8 (3). , http://dx.doi.org/10.1371/journal.pone.0058636Yang, J., Wang, N., Zhu, Y., Feng, P., Roles of SIRT1 in high glucose-induced endothelial impairment: Association with diabetic atherosclerosis (2011) Arch Med Res, 42 (5), pp. 354-360. , http://dx.doi.org/10.1016/j.arcmed.2011.07.005Botden, I.P., Zillikens, M.C., de Rooij, S.R., Langendonk, J.G., Danser, A.H., Sijbrands, E.J., Variants in the SIRT1 gene may affect diabetes risk in interaction with prenatal exposure to famine (2012) Diabetes Care, 35 (2), pp. 424-426. , http://dx.doi.org/10.2337/dc11-1203Kilic, U., Gok, O., Bacaksiz, A., Izmirli, M., Elibol-Can, B., Uysal, O., SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases (2014) PLoS One, 9. , http://dx.doi.org/10.1371/journal.pone.0090428Mateo-Gallego, R., Bea, A.M., Jarauta, E., Perez-Ruiz, M.R., Civeira, F., Age and sex influence the relationship between waist circumference and abdominal fat distribution measured by bioelectrical impedance (2012) Nutr Res, 32 (6), pp. 466-469. , http://dx.doi.org/10.1016/j.nutres.2012.05.004Carr, M.C., The emergence of the metabolic syndrome with menopause (2003) J Clin Endocrinol Metab, 88 (6), pp. 2404-2411. , http://dx.doi.org/10.1210/jc.2003-030242Gupta, R., Deedwania, P.C., Gupta, A., Rastogi, S., Panwar, R.B., Kothari, K., Prevalence of metabolic syndrome in an Indian urban population (2004) Int J Cardiol, 97 (2), pp. 257-261. , http://dx.doi.org/10.1016/j.ijcard.2003.11.003Machado, U.F., Schaan, B.D., Seraphim, B.M., Glucose transporters in the metabolic syndrome (2006) Arq Bras Endocrinol Metab, 50 (2), pp. 177-189. , http://dx.doi.org/10.1590/S0004-27302006000200004Schäfer, S., Kantartzis, K., Machann, J., Venter, C., Niess, A., Schick, F., Lifestyle intervention in individuals with normal versus impaired glucose tolerance (2007) Eur J Clin Invest, 37 (7), pp. 535-543Johannsson, G., Mårin, P., Lönn, L., Ottosson, M., Stenlöf, K., Björntorp, P., Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure (1997) J Clin Endocrinol Metab, 82 (3), pp. 727-734. , http://dx.doi.org/10.1210/jcem.82.3.3809Schneider, H., Klotsche, J., Wittchen, H., Stalla, G., Schopohl, J., Kann, P., Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency (2011) Clin Endocrinol, 75 (6), pp. 825-830. , http://dx.doi.org/0.1111/j.1365-2265.2011.04137.xNagasaki, K., Tsumanuma, I., Yoneoka, Y., Jinguji, S., Ogawa, Y., Kikuchi, T., Metabolic effects of growth hormone replacement in two pediatric patients with growth without growth hormone (2010) Endocr J, 57 (9), pp. 771-775. , http://doi.org/10.1507/endocrj.K10E-180Arafat, A.M., Möhlig, M., Weickert, M.O., Schöfl, C., Spranger, J., Pfeiffer, A.F., Improved insulin sensitivity, preserved beta cell function and improved wholebody glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: A pilot study (2010) Diabetologia, 53 (7), pp. 1304-1313. , http://doi.org/10.1007/s00125-010-1738-4Douyon, L., Schteingart, D.E., Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion (2002) Endocrinol Metab Clin North Am, 3 (1), pp. 173-189Kumar, H.K., Yadav, R.K., Prajapati, J., Reddy, C.V., Raghunath, M., Modi, K.D., Association between thyroid hormones, insulin resistance, and metabolic syndrome (2009) Saudi Med J, 30 (7), pp. 907-911Estivalet, A.A., Leiria, L.B., Dora, J.M., Rheinheimer, J., Bouças, A.P., Maia, A.L., D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients (2011) Obesity, 19 (4), pp. 825-832. , http://doi.org/10.1038/oby.2010.231Nagai, N., Sakane, N., Kotani, K., Hamada, T., Tsuzaki, K., Moritani, T., Uncoupling protein 1 gene-3826 A/G polymorphism is associated with weight loss on a short-term, controlled-energy diet in young women (2011) Nutr Res, 31 (4), pp. 255-261. , http://doi.org/10.1016/j.nutres.2011.03.010